Phase 4 N=69 Long-Term Growth and Skeletal Effects of Early Growth Hormone Treatment in Turner Syndrome
Turner Syndrome
Primary: Most Mature Height Standard Deviation Score (SDS) — -1.37; -1.60 standard deviation score
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=8 Study of the Presence and Extent of Corneal Disturbance Associated With B+L Biotrue MPS Used With B+L PureVision Lenses
Keratitis
Primary: Number of Participants Wiith Corneal Staining — 1; 6 participants
Phase 4 N=124 Safety and Efficacy of Lubiprostone in Pediatric Patients With Constipation
Constipation
Primary: Frequency of Spontaneous Bowel Movements — 2.47; 3.02; 3.84 spontaneous bowel movements per week
Phase 4 N=49 Intranasal Fentanyl for Initial Treatment of a Vaso-occlusive Crisis
Anemia, Sickle Cell · Pain
Primary: Change in Pain Score 20 Minutes After Administration of Study Drug — 1; 2 units on a scale — p=0.048
Phase 4 N=359 PROspective Non-interventional Open laBEl Trial for TARGIN in Korean Patients With Cancer Pain
Cancer
Primary: Change in Numeric Rating Scales (NRS) Score — -1.89 units on a scale
Phase 4 N=40 Harmonic ACE®+7 Shears in Laparoscopic Hysterectomy
Benign Disease Where Total Hysterectomy is Indicated
Primary: Percentage of Subjects Achieving Hemostasis at the Named Vessel/Pedicle (UA or UP) on the Left Side. — 97.5 percentage of participants
Phase 4 N=8 Repository Corticotropin Injection To Treat Rheumatoid Arthritis Patients Who Have Failed Three Biologic Therapies.
Rheumatoid Arthritis
Primary: Change From Baseline in the Ritchey-Camp Articular Index — 10.25; 9 joints
Phase 4 N=64 Mask Leak With Nasal Cannula in Noninvasive Positive Pressure Ventilation
Mechanical Ventilation Pressure High
Primary: Face Mask Leak Measured in Liters Per Minute by the Noninvasive Positive Pressure Ventilation Machine — 0; 0 Liters per minute
Phase 4 N=618 Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and the Relationship Between Scan Status and Cognitive Decline
Alzheimer's Disease
Primary: Clinical and Diagnostic Change in Patient Management — 68.0; 55.5 percentage of patients — p=0.002
Phase 4 N=180 Efficacy and Safety of Peg-Interferon Alpha-2a Plus Ribavirin in Genotype 1 Chronic Hepatitis C Participants Co-Infected With Human Immunodeficiency Virus
Hepatitis C, Chronic
Primary: Percentage of Participants With Sustained Virologic Response (SVR) — 23.8; 36.5 percentage of participants — p=0.0536
Phase 4 N=120 Methadone and Hydromorphone For Spinal Surgery
Hydromorphone Use · Acute Postoperative Pain · Patient Satisfaction
Primary: Hydromorphone Use at 24 Hours — 4.56; 9.9 milligrams
Phase 4 N=140 BLQ Study: A Study of a Protease Inhibitor With Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With HIV-1.
HIV Infections
Primary: Number of Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Ribonucleic Acid (RNA) Viral Load <50 Copies/mL — 79; 78 participants
Phase 4 N=1,012 Impact Of Eplerenone On Cardiovascular Outcomes In Patients Post Myocardial Infarction
Myocardial Infarction
Primary: First Event of Cardiovascular Mortality, Re-hospitalization or Extended Initial Hospital Stay Due to Diagnosis of Heart Failure, Sustained Ventricular Tachycardia or…
Phase 4 N=37 BREATHE 5-OL: Tracleer (Bosentan) in Patients With Pulmonary Arterial Hypertension Related to Eisenmenger Physiology
Pulmonary Arterial Hypertension
Primary: Change in 6-minute Walk Distance — 13.5 m
Phase 4 N=40 Safety and Efficacy Study of Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients
BK Virus Infection
Primary: Evidence of Reduction of BK Viruria and/or Clearance of BK Viremia — 11; 8 participants — p=0.53